Brandas, Chiara
Brandas, Chiara
Istituto di Ricerca Genetica e Biomedica - IRGB - Sede Secondaria Milano
Mostra
records
Risultati 1 - 2 di 2 (tempo di esecuzione: 0.006 secondi).
In Silico and In Vitro Evaluation of the Mechanism of Action of Three VX809-Based Hybrid Derivatives as Correctors of the F508del CFTR Protein
2023 Baroni, D.; Scarano, N.; Ludovico, A.; Brandas, C.; Parodi, A.; Lunaccio, D.; Fossa, P.; Moran, O.; Cichero, E.; Millo, E.
Nbd2 is required for the rescue of mutant f508del cftr by a thiazole-based molecule: A class ii corrector for the multi-drug therapy of cystic fibrosis
2021 Brandas, C.; Ludovico, A.; Parodi, A.; Moran, O.; Millo, E.; Cichero, E.; Baroni, D.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| In Silico and In Vitro Evaluation of the Mechanism of Action of Three VX809-Based Hybrid Derivatives as Correctors of the F508del CFTR Protein | 1-gen-2023 | Baroni, D.; Scarano, N.; Ludovico, A.; Brandas, C.; Parodi, A.; Lunaccio, D.; Fossa, P.; Moran, O.; Cichero, E.; Millo, E. | |
| Nbd2 is required for the rescue of mutant f508del cftr by a thiazole-based molecule: A class ii corrector for the multi-drug therapy of cystic fibrosis | 1-gen-2021 | Brandas, C.; Ludovico, A.; Parodi, A.; Moran, O.; Millo, E.; Cichero, E.; Baroni, D. |